NCT05349162

Epicardial vs. Transvenous ICDs in Children

Epicardial Versus Transvenous Implantable Cardioverter Defibrillators in Children

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 131 (actual)
• Sponsor: Paris Cardiovascular Research Center (Inserm U970) · Other Government
• Sex: All
• Age: 0 Years – 18 Years
• Healthy volunteers: —

Summary

This observational study included all patients \<18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.

Conditions

• Implantable Cardioverter Defibrillator Complications
• Implantable Defibrillator User

Interventions

Type	Name	Description
DEVICE	Implantable cardioverter defibrillator use	Implantation of an implantable cardioverter defibrillator (epicardial or transvenous)

Timeline

• Start date: 2003-01-01
• Primary completion: 2021-01-01
• Completion: 2022-04-01
• First posted: 2022-04-27
• Last updated: 2022-04-27